A Multicenter, Open-label Extension Trial to Assess the Long-term Safety and Tolerability of Lacosamide as Adjunctive Therapy in Subjects With Partial-onset Seizures

Trial Profile

A Multicenter, Open-label Extension Trial to Assess the Long-term Safety and Tolerability of Lacosamide as Adjunctive Therapy in Subjects With Partial-onset Seizures

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Apr 2015

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Partial epilepsies
  • Focus Adverse reactions
  • Sponsors UCB
  • Most Recent Events

    • 14 Jul 2011 Actual initiation date (Apr 2008) added as reported by ClinicalTrials.gov (Extension trial, NCT00655486).
    • 14 Jul 2011 Actual initiation date (Apr 2008) added as reported by ClinicalTrials.gov (Extension trial, NCT00655486).
    • 14 Jul 2011 Actual trial end date is Jun 2010 as reported by ClinicalTrials.gov (Extension trial, NCT00655486).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top